Journal article

EURAP registry: inadequate monitoring of prescribed drugs in pregnancy Reply

Torbjorn Tomson, Dina Battino, Erminio Bonizzoni, John Craig, Dick Lindhout, Emilio Perucca, Anne Sabers, Sanjeev V Thomas, Frank Vajda

The Lancet Neurology | ELSEVIER SCIENCE INC | Published : 2018


Funding Acknowledgements

TT is an employee of Karolinska Institutet (Stockholm, Sweden) and is Associate Editor for the Epileptic Disorders journal. TT has also received speaker's honoraria to his institution from Eisai, UCB, Actavis, BMJ India, Livanova, and Sandoz; honoraria to his institution for advisory boards from UCB and Eisai; and research support from Stockholm County Council, CURE, GlaxoSmithKline, UCB, Eisai, Bial, and Novartis. DB has received speaker's honoraria from UCB and Sanofi. EB has received consultancy fees from Italfarmaco, Zambon, Polichem, Roche, and Sanofi-Aventis. JC has received research grants and speaker's honoraria from UCB Pharma, Eisai, GlaxoSmithKline, Sanofi Synthelabo, Pfizer, and Janssen-Cilag. DL has received research grants from Janssen-Cilag, GlaxoSmithKline, Pfizer, and the Netherlands Epilepsy Foundation. EP has received research funds from the European Union, the Italian Ministry of Health, the Italian Ministry for Education and University, and the Italian Medicines Agency; has received speaker's, consultancy fees, or research grants from Eisai, Livanova, Medichem, Sanofi, Sandoz, and Sun Pharma; and has been on the safety or advisory boards of UCB Pharma and GW Pharma. AS has received consultancy or lecture fees for Eisai Denmark and UCB Nordic; and has received travel support from Eisai, Biogen, and UCB Nordic. SVT has received research support from the Indian Council of Medical Research, speaker's honorarium from BMJ India, and Royalty from Wiley Publishing House. FV declares no competing interests.